Publications by authors named "Timothy D Moore"

Claim this Profile
N
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, Priya Rastogi, Joseph P Costantino, Timothy D Moore

J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
William Small, Jennifer L James, Timothy D Moore, Dan J Fintel, Stephen T Lutz

Am J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
George T Budd, William E Barlow, Halle C F Moore, Timothy J Hobday, James A Stewart, Timothy D Moore

J Clin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.
Roxana S Dronca, Jacob B Allred, Domingo G Perez, Wendy K Nevala, Elizabeth A T Lieser, Timothy D Moore

Am J Clin Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors.
Anthony W Tolcher, Wendi V Rodrigueza, Drew W Rasco, Amita Patnaik, Kyriakos P Papadopoulos, Timothy D Moore

Cancer Chemother Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making the connection: a qualitative study of brokerage in Aboriginal health in a metropolitan area of Victoria and a regional area of New South Wales.
Melanie S Cheng, Angela Clarke, Timothy D Moore, Phyllis M Lau

Aust Health Rev· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
Shannon Puhalla, Ewa Mrozek, Donn Young, Susan Ottman, Anne McVey, Timothy D Moore

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.
Edgardo Rivera, M Haim Erder, Timothy D Moore, Thomas L Shiftan, Chris A Knight, Laurence Danel-Moore

Cancer· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis